12 August 2003 AmpC  -Lactamases & their detection David Livermore Health Protection Agency, Colindale, London.

Slides:



Advertisements
Similar presentations
Detection of Carbapenemases From a Technologist’s Perspective
Advertisements

Detection of ESBLs & AmpC
Detection of b-Lactamase-Mediated Resistance
Game plan Lecture Antibiotics Antibiotic resistance Gene transfer Transformation Transduction Conjugation Lab Lab Exam Pre-lab Transformation.
Recent Changes to the Recommendations Jenny Andrews.
Emerging Antimicrobial Resistance in Texas The new ESBLs.
2009 CLSI M100-S19 Update Nebraska Public Health Laboratory.
Methods for detection β-lactamases Sarah Alharbi.
New Resistance in Gram Negative Rods (GNRs)
Klebsiella oxytoca and K1 enzyme
Welcome to the CDS Workshop Jeanette Pham Syd Bell Hobart 2011.
A review and update of the CDS test CDS Workshop ASM 2009 Perth.
WELCOME to the CDS WORKSHOP Sydney Excel Spreadsheet for Registration.
Plate 1a: Staphylococcus aureus resistant to penicillin (P0.5) only. Note the annular radius of the zone of inhibition of 9.5 mm around the cefoxitin (FOX.
Plasmid mediated Metallo-Beta- Lactamase (MBL) Plasmid mediated Hydrolyses all beta-lactam (except aztreonam) Inhibited by EDTA Binds zinc (Zn 2+ ) Pseudomonas.
New Product Anouncement Cephalosporinase - Plates.
Resistance to  -lactam antibiotics within the Enterobacteriaceae Paul D. Fey, Ph. D. University of Nebraska Medical Center.
COL Helen Viscount, PhD, D(ABMM) LTC Steven Mahlen, PhD, D(ABMM)
Beta lactam antibiotics & Other cell wall synthesis inhibitors
BSAC User Group Meeting 2007 BSAC recommendations for interpreting the susceptibility of urinary tract isolates Jenny Andrews.
ANTIMICROBIAL RESISTANCE
Ceftazidime resistance in a Salmonella enterica serotype Bareilly in Ireland N.DeLappe, D Morris, C.O’Hare, E.Costello, G.Corbett-Feeney and M.Cormican.
Detection of  -lactamase- mediated resistance David Livermore Health Protection Agency, Colindale, London.
Mechanisms of Antimicrobial Resistance Jing-Jou Yan, M.D. Department of Pathology National Cheng Kung University Hospital 26/12/2007.
Vitek 2 – A User Experience.
ESBL, MBL and Amp C beta lactamase detection DEPARTMENT OF MICROBIOLOGY JIPMER PUDUCHERRY.
SCACM Workshop Detection of Antibiotic Resistance in Gram-Negative Bacilli October 3, 2007 Detection and Reporting of Beta-lactam Resistance in Enterobacteriaceae.
Beta lactams. INHIBITORS OF CELL WALL SYNTHESIS Natural: Pencillinase Resistant: (Anti staph) 1)Benzyl pencillin (G) k+ Na+1) oxcillin 2)Procaine pencillin.
Mechanisms of Antibiotic Resistance
김의종(집필대표), 강정옥, 김미나, 김민중, 김성일, 이경원, 이도현, 이장호, 이남용, 이창규, 신종희, 장철훈, 최혜심
What’s happening now ? Epidemiology of (carbapenem) resistance Neil Woodford HPA – AMRHAI - Colindale.
β-lactamase inhibitors
Supplemental testing methods
Dr. Laila M. Matalqah Ph.D. Pharmacology
Dr. Iman M. Fawzy Clinical Pathology MD, PhD Mansoura, Egypt
ESBL, AmpC -lactamase 표준진단법
Prof KN Prasad, MD Department of Microbiology,
(Ambler class A, Bush group 2) Inhibited by CA
4/28/2017 AST.
MRSA, ESBLs and Carbapenem Resistance
Justin Jones, PharmD, BCPS Critical Care Pharmacist Sanford Medical Center, Fargo Bent or Broken? Re-evaluating the β-lactam backbone for ESBL-producing.
C-158 Genetic and Biochemical Characterisation of OXA-405, a New Extended Spectrum Class D -Lactamase from Serratia marcescens L. Dortet1,2, S. Oueslati1,
Cephalosporins Four Generations! Bactericidal & Time-Dependent!
Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae
Current Status of Antimicrobial Resistance
8th Annual Infection Prevention Conference 23rd June 2011, Harrogate
N°XXXX Rapid detection of extended-spectrum BETA-lactamase producing Enterobacteriaceae from urine using the ESBL NDP test Patrice Nordmann, Laurent Poirel,
Standardisation – What does this mean for the CDS?
Alphabet Soup: MRSA – ESBL - CRE
The Role of the Microbiology Laboratory in AMS programs
Antimicrobial Spectrum of Activity Visual Learning Exercises (“Flower Diagrams”) This work is licensed under the Creative Commons Attribution-NonCommercial-
Cell wall inhibitor Cephalosporins Dr. Naza M. Ali Lec D
1200 Brussels - Belgium Temocillin is not substrate for OprD2 porin from Pseudomonas aeruginosa H. Chalhoub1,
Case Presentation – January 28th, 2015 Brian Skinner, PharmD
Clinico-Pathological Conference (CPC) Meet
Pharmacology of Cephalosporins: General Overview
Extended-spectrum beta-lactamases(ESBL)
Figure 1. Molecular modeling of : a) GES-1 and b) GES-1P174E
Inducible β-lactamase-mediated resistance to third-generation cephalosporins  Ronald N Jones, Fernando Baquero, Gaetano Privitera, Matsuhisa Inoue, Bernd.
BSAC Bacteraemia Resistance Surveillance Update 2013
C th Interscience Conference on Antimicrobial Agents and Chemotherapy October 25-28, Washington, DC Examining Temocillin Activity in Combination.
L. Poirel, P. Nordmann  Clinical Microbiology and Infection 
Beta-lactam antibiotics
The need for new antibiotics
Phenotypic detection of extended-spectrum β-lactamase production in Enterobacteriaceae: review and bench guide  L. Drieux, F. Brossier, W. Sougakoff,
L.-T. Wu, S.-W. Hung, Y.-C. Chuang, H.-E. Chen, R.N. Jones, W.-L. Yu 
TRAINING PRESENTATION
β- Lactamase Inhibitor
Stabilization in prevalence of ESBLs & ciprofloxacin non-susceptibility in Enterobacteriaceae from blood in the UK and Ireland Rosy Reynolds, Russell.
Multi-centre evaluation of a phenotypic extended spectrum β-lactamase detection guideline in the routine setting  T.N. Platteel, J.W. Cohen Stuart, A.J.
Presentation transcript:

12 August 2003 AmpC  -Lactamases & their detection David Livermore Health Protection Agency, Colindale, London

 -Lactamase-stable cephs CONH O COOH R C N OR H2NH2N Oxyimino-aminothiazolyl stability to classical TEM/SHV SN S N

 -Lactamase classes

AmpC enzymes Mol wt. c. 40,000; alkaline pI Hydrolytic activity 1 st gen cephs –rapid 2/3 ceph cephs –slow but kinetically efficient 4-gen cephs –slow, kinetically inefficient Carbapenems –nearly stable…. not quite! Not inhibited by clavulanate; poorly inhibited by sulphones

AmpC  -lactamases Basal in: E. coli & shigellae Inducible in: Enterobacter spp. C. freundii M. morganii Serratia spp. P. aeruginosa 2nd, 3rd gen cephs: Labile, but weak inducers, select derepressed mutants [  -lactam] Amt  -lactamase Derepressed Inducible

Induction of AmpC Cell wall constantly re-cycled Yields disaccharide tri-peptides (DTPs) –Absorbed by AmpG –Cleaved by AmpD = N-acetyl-muramyl-L-alanine amidase Excess DTPs bind AmpR, activating ampC

Uninduced AmpC Wall fragments recycled by AmpD AmpR in repressor conformation ampC (  -lactamase gene) NOT expressed ampCamp R ampD AmpDAmpR

Induced AmpC ampCamp R ampD More recycling: AmpD overwhelmed Wall fragments convert AmpR to activator ampC (  -lactamase gene) expressed AmpD  -lactamase

Derepressed AmpC ampCamp R ampD ampD inactivated by mutation AmpR constantly converted to activator ampC hyper-expressed  -lactamase++

Strong & weak inducers Strong inducerWeak inducer Labile1 st gen cephs Ampicillin 3 rd gen cephs Piperacillin Aztreonam StableImipenem(Temocillin) (Meropenem) Strong inducer induces below MIC, weak doesn’t

MICs (mg/L) for E. cloacae AmpC mutants

MICs (mg/L) for P. aeruginosa AmpC mutants

Strong inducers –e.g. imipenem What selects derepression? No! – derepressed no more R than inducible All weak inducers? No- Not if they are stable LABILE weak inducers? Yes! Derepressed are R, whilst inducible cells are S, so derepressed are selected

Over-run by mutants Derepression occurs in 1 cell / 10 7 Confers resistance to 3-gen cephs Overnight, one cell can give 10 9 progeny Selection in therapy can cause R x failure... Mutant emerges randomly Sensitive cells killed by antibiotic Mutant’s progeny overrun

Initial isolation of 3 rd -gen cephR Enterobacter, & prior R x Chow et al. Ann Intern Med 1991, 115,

Selecting Enterobacter R to 3 rd gen cephs during R x Kaye et al. AAC 2001, 45, 2628; Cosgrove et al. Arch Intern Med 2002, 162, 185

Plasmidic AmpC enzymes Escaping from enterobacterial and Aeromonas chromosomes Many good reports since 1991 CMY, MOX, FOX, LAT, DHA, ACT & BIL enzymes

Sources of plasmid AmpC ClassSourceExamples CITC. freundiiCMY-2 to 7; LAT-1,3,4 ENTEnterobacter spp.ACT-1; MIR-1 FOXAeromonas spp.FOX-1 to -5; MOXAeromonas spp.MOX-1,-2; CMY-1,7 & 8 DHAM morganiiDHA-1, -2 ACCH. alveiACC-1

Plasmid AmpC Jenks et al J Antimicrob Chemother 35,

Enzymes in 1127 cephR isolates from 16 labs in S England, 2004 Potz et al., JAC, 2006 in press

Prevalence of mechanisms: BSAC bacteraemia surveillance,

Inducible AmpC Cefoxitin Ceftazidime But mutational derepression is the problem, not induction Better predict risk from species I/D

Suspect derepressed / plasmid AmpC if: Resistant 3-gen cephs, NOT cefepime & cefpirome Resistant to cefoxitin (but more ESBL producers R, too, nowadays) No ceph/clav synergy

Geometric mean MICs (mg/L): AmpC producers; 2004 London SE survey E. coli AmpC E. coli ESBL Enterobacter AmpC Enterobacter ESBL Cefotaxime Ceftazidime Cefepime Cefpirome Cefuroxime35>64 Cefoxitin5117>6451

Some wrinkles… AmpC-derepressed M. morganii are S to pip/tazo AmpC derepressed Serratia are S to ceftazidime Cefoxitin R an unreliable marker for Providencia, Morganella & Serratia spp. –Inducible & derepressed strains may appear I or S AmpC derepressed P. aeruginosa tend to be S to carbenicillin / efflux mutants are R Life complicated if there’s an ESBL with the AmpC

Confirmatory tests for AmpC Seek cefotaxime/cloxacillin synergy –Cefotaxime MIC +100 mg/l cloxacillin –Zones of cefotaxime 30  g discs on agar mg/L cloxacillin –No agreed interpretive standards Can also use phenylboronic acid as inhibitor DHA enzymes inducible & especially difficult to detect

Cefotaxime combinations vs. AmpC E. coli: London SE survey

Cefotaxime / cloxacillin tests for AmpC

3-D test for AmpCs Plate seeded with cefoxitin S indicator strain Cut cross in agar, heavily inoculated with test strain Cefoxitin disc Looks for distortion where cross intersects the cefoxitin zone

Clover leaf (3 dimensional) test for AmpC Test strain E. cloacae, AmpC derepressed Indicator E. coli NCTC10418 Disc Cefoxitin 30  g

Clover leaf (3 dimensional) test for cephalosporinase Test strain E. cloacae, AmpC derepressed Indicator E. coli NCTC10418 Disc Cefotaxime 30  g

Phenyl boronic acid for detection of plasmid AmpC Expansion (mm) of FOX 30 zone with 400  g phenyl boronic acid Fold MIC reduction for cefoxitin mg/L phenyl boronic acid Kleb MOX E. coli LAT Kleb DHA Kleb DHA E. coli ACC-144 Kleb ACT ALL ESBL +ve<2<2<2<2 Coudron JCM

Disc tests for AmpC 60 E. coli & Klebsiella : cefoxitin MICs reduced >4-fold by 100 mg/L cloxacillin % with >5 mm zone expansion Cefoxitin + cloxacillin 100  g 86% Cefoxitin + BZB 64  g 89% Cefpodoxime + BZB 64  g 97% Cefpodoxime + clav + BZB 64  g 100% BZB: benzo(b)thiophene-2-boronic acid Brenwald et al., JAC 2005, 56, 600

Cefoxitin R isolates in phenyl boronic acid / cefoxitin tests 3-DPhenyl boronic, disc Phenyl boronic MIC K. pneumoniae K. oxytoca E. coli P. mirabilis Coudron JCM

Multiplex detection of plasmid AmpC genes Method of Perez-Perez & Hanson JCM 2002, 40, 2153

AmpC hyperproducers : options Active Carbapenems Temocillin 4-gen cephs Not active Penicillins except temocillin Inhibitor combinations 1, 2, 3-gen cephs Aztreonam

AmpC Summary Mutant selection the problem, not induction Selection mostly in therapy with 3-gen cephs AmpC types spreading to plasmids Suspect AmpC if: –R 3 rd, not 4 th gen cephs; cefoxitin R, no ceph/clav synergy Confirmatory tests poorly standardised, exploit synergy with cloxacillin or phenyl boronic acids